UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Prestige Consumer Healthcare
PBH
$2.5B
| $19.9M | ﹤0.01% |
254,673
+125,334
| +97% | +$9.73M |
|
2327
Casella Waste Systems
CWST
$5.7B
| $19.9M | ﹤0.01% |
187,645
+146,470
| +356% | +$15.5M |
|
2328
Sociedad Química y Minera de Chile
SQM
$19.8B
| $19.8M | ﹤0.01% |
544,965
+470,273
| +630% | +$18.4M |
|
2329
CALL
Southern Company
SO
$107B
| $19.8M | ﹤0.01% |
240,700
+86,400
| +56% | +$7.58M |
|
2330
PUT
Rivian
RIVN
$22.4B
| $19.8M | ﹤0.01% |
1,486,800
-2,058,900
| -58% | -$23.7M |
|
2331
Buckle
BKE
$2.35B
| $19.8M | ﹤0.01% |
388,927
+356,661
| +1,105% | +$16.9M |
|
2332
Penumbra
PEN
$12.7B
| $19.8M | ﹤0.01% |
83,173
+66,939
| +412% | +$15.2M |
|
2333
Lumentum
LITE
$65.6B
| $19.7M | ﹤0.01% |
235,152
+145,635
| +163% | +$11.4M |
|
2334
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.68B
| $19.7M | ﹤0.01% |
1,201,816
+352,055
| +41% | +$5.83M |
|
2335
Penske Automotive Group
PAG
$14.3B
| $19.6M | ﹤0.01% |
128,831
+77,673
| +152% | +$12.3M |
|
2336
QuantumScape Corp
QS
$3.38B
| $19.6M | ﹤0.01% |
3,778,824
+3,550,168
| +1,553% | +$18.6M |
|
2337
TripAdvisor
TRIP
$1.62B
| $19.6M | ﹤0.01% |
1,326,910
+745,869
| +128% | +$10.9M |
|
|
HEES
2338
DELISTED
H&E Equipment Services
HEES
| $19.6M | ﹤0.01% |
400,273
+314,331
| +366% | +$17.1M |
|
2339
PUT
Robinhood
HOOD
$84.4B
| $19.6M | ﹤0.01% |
+525,000
| New | +$17M |
|
2340
PUT
BioNTech
BNTX
$23.2B
| $19.6M | ﹤0.01% |
171,600
+4,300
| +3% | +$491K |
|
2341
CALL
CVS Health
CVS
$128B
| $19.5M | ﹤0.01% |
435,400
+257,639
| +145% | +$14.5M |
|
2342
CALL
Biogen
BIIB
$30.6B
| $19.5M | ﹤0.01% |
127,800
+6,500
| +5% | +$1.1M |
|
2343
CALL
Zscaler
ZS
$26.3B
| $19.5M | ﹤0.01% |
108,298
+30,300
| +39% | +$5.87M |
|
2344
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.08B
| $19.5M | ﹤0.01% |
635,132
-8,749
| -1% | -$269K |
|
2345
Murphy Oil
MUR
$5.29B
| $19.5M | ﹤0.01% |
644,788
+312,981
| +94% | +$10.1M |
|
2346
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.72B
| $19.5M | ﹤0.01% |
792,995
+124,421
| +19% | +$3.11M |
|
2347
TG Therapeutics
TGTX
$7.57B
| $19.5M | ﹤0.01% |
647,097
-18,858
| -3% | -$541K |
|
2348
Crane NXT
CXT
$3.08B
| $19.4M | ﹤0.01% |
333,853
+115,351
| +53% | +$6.62M |
|
2349
CALL
Target
TGT
$67.2B
| $19.4M | ﹤0.01% |
143,700
+67,700
| +89% | +$9.7M |
|
2350
Universal Corp
UVV
$1.31B
| $19.4M | ﹤0.01% |
353,420
+247,315
| +233% | +$13.3M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.